Your browser doesn't support javascript.
loading
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).
Kato, Ken; Satoh, Taroh; Muro, Kei; Yoshikawa, Takaki; Tamura, Takao; Hamamoto, Yasuo; Chin, Keisho; Minashi, Keiko; Tsuda, Masahiro; Yamaguchi, Kensei; Machida, Nozomu; Esaki, Taito; Goto, Masahiro; Komatsu, Yoshito; Nakajima, Takako Eguchi; Sugimoto, Naotoshi; Yoshida, Kazuhiro; Oki, Eiji; Nishina, Tomohiro; Tsuji, Akihito; Fujii, Hirofumi; Kunieda, Kenji; Saitoh, Soh; Omuro, Yasushi; Azuma, Mizutomo; Iwamoto, Yasuo; Taku, Keisei; Fushida, Sachio; Chen, Li-Tzong; Kang, Yoon-Koo; Boku, Narikazu.
Afiliación
  • Kato K; Division of Gastrointestinal Medical Oncology, National Cancer Center Hospital, 5-1-1, Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
  • Satoh T; Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Muro K; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yoshikawa T; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Tamura T; Department of Gastric Surgery, National Cancer Center Hospital, Tokyo, Japan.
  • Hamamoto Y; Department of Medical Oncology, Kindai University, Faculty of Medicine, Osaka, Japan.
  • Chin K; Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan.
  • Minashi K; Keio Cancer Center, School of Medicine, Keio University, Tokyo, Japan.
  • Tsuda M; Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yamaguchi K; Clinical Trial Promotion Department, Chiba Cancer Center, Chiba, Japan.
  • Machida N; Department of Gastroenterological Oncology, Hyogo Cancer Center, Akashi, Japan.
  • Esaki T; Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan.
  • Goto M; Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Komatsu Y; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Nakajima TE; Department of Gastrointestinal and Medical Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Sugimoto N; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan.
  • Yoshida K; Division of Cancer Chemotherapy, Hokkaido University Hospital Cancer Center, Sapporo, Japan.
  • Oki E; Department of Clinical Oncology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Nishina T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Tsuji A; Department of Surgical Oncology, Gifu University Graduate School of Medicine, Gifu, Japan.
  • Fujii H; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Kunieda K; Department of Gastrointestinal Medical Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
  • Saitoh S; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Omuro Y; Department of Medical Oncology, Kagawa University, Takamatsu, Japan.
  • Azuma M; Department of Clinical Oncology, Cancer Center Jichi Medical University Hospital, Shimotsuke, Japan.
  • Iwamoto Y; Department of Medical Oncology, Saku Central Hospital Advanced Care Center, Saku, Japan.
  • Taku K; Internal Medicine, Misawa City Hospital, Misawa, Japan.
  • Fushida S; Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Chen LT; Department of Gastroenterology, Kitasato University School of Medicine, Sagamihara, Japan.
  • Kang YK; Medical Oncology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan.
  • Boku N; Medical Oncology, Shizuoka General Hospital, Shizuoka, Japan.
Gastric Cancer ; 22(2): 344-354, 2019 03.
Article en En | MEDLINE | ID: mdl-30506519
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Terapia Recuperativa / Antineoplásicos Inmunológicos / Nivolumab Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Terapia Recuperativa / Antineoplásicos Inmunológicos / Nivolumab Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Gastric Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón